LAUSR

Tim Hubbard: The project was really set up in 2012 to see—because genome sequencing had got so much cheaper—there was a government report saying that it was time to start thinking about doing that in the health service. So that’s what the project is: to see if you can use whole-genome sequencing directly in a health service for clinical care and whether there’s enough value to implementing it. And, in fact, for rare diseases, we’ve decided there’s enough value and it will be folded into direct care this year.